Dyspepsia and gastro-oesophageal reflux disease
Everything NICE has said on investigating and managing dyspepsia and gastro-oesophageal reflux disease in an interactive flowchart
Search results
8 results for Omeprazole
-
-
Short bowel syndrome - teduglutide [ID885]
In development [GID-TA10048] Expected publication date: TBC
-
Photodynamic therapy for Barrett's oesophagus (IPG350)
Evidence-based recommendations on photodynamic therapy (PDT) for treating Barrett's oesophagus
-
Acute upper gastrointestinal bleeding in over 16s: management (CG141)
This guideline covers how upper gastrointestinal bleeding can be effectively managed in adults and young people aged 16 years and older. It aims to identify which diagnostic and therapeutic steps are useful so hospitals can develop a structure in which clinical teams can deliver an optimum service for people who develop this condition.
-
Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate (ESUOM4)
Summary of the evidence on oral magnesium glycerophosphate for preventing recurrent hypomagnesaemia to inform local NHS planning and decision-making
-
The way to medicines optimisation is through the stomach - tackling high prescribing levels using the NICE Dyspepsia guideline to review proton pump inhibitor (PPI) prescribing.
England and Wales in 2011 more than 40 million items were dispensed; with omeprazole and lansoprazole achieving 5th and 10th position...
-
Stretta System for gastro-oesophageal reflux disease (MIB74)
NICE has developed a medtech innovation briefing (MIB) on the Stretta System for gastro-oesophageal reflux disease
-
Suspected cancer recognition and referral
Everything NICE has said on suspected cancer, recognition and selection for referral or investigation in primary care in an interactive flowchart